Nasal administration
Top View
- Journal of Drug Delivery and Therapeutics Orodispersible Tablet in Treatment of Migraine: Opportunities, Challenges and Recent A
- Guideline on the Pharmaceutical Quality of Inhalation and Nasal Products
- 1. Introduction
- Desmopressin Orally Disintegrating Tablet in Japanese Patients with Central Diabetes Insipidus: a Retrospective Study of Switching from Intranasal Desmopressin
- A Short Review on the Intranasal Delivery of Diazepam for Treating Acute Repetitive Seizures
- Opioid Antidote- Evzio® (Naloxone Hydrochloride Auto-Injection)
- Does the Intranasal Route Pass the Sniff Test?
- Nasal Drug Delivery – in Vitro Studies on Factors Influencing Permeability and Implications on Absorption
- Intranasal Medication Administration by Mucosal Atomization Device (MAD®)
- Mucosal Vaccination Via the Respiratory Tract
- Intranasal Medication Administration
- Nasal Drug Delivery Devices: Characteristics and Performance in a Clinical Perspective—A Review
- FDA Advisory Committee on the Most Appropriate Dose Or Doses of Naloxone to Reverse the Effects of Life-Threatening Opioid Overdose in the Community Settings
- 1746.2 Protocol for Pharmacists Furnishing Nicotine Replacement Products
- The Quality of Instructional Youtube Videos for the Administration of Intranasal Spray: Observational Study
- ( 12 ) United States Patent ( 10 ) Patent No .: US 10,806,709 B2 Fleming (45 ) Date of Patent : * Oct
- Drug Delivery Via the Upper Nasal Space: a Novel Route for Anesthesiologists, Intensivists and Emergency Department Physicians?
- Evidence for Intranasal Oxytocin Delivery to the Brain: Recent Advances and Future Perspectives